Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Invested Capital (2021 - 2025)

Bioregenx's Invested Capital history spans 5 years, with the latest figure at -$3.5 million for Q4 2025.

  • Quarterly results put Invested Capital at -$3.5 million for Q4 2025, down 57.67% from a year ago — trailing twelve months through Dec 2025 was -$3.5 million (down 57.67% YoY), and the annual figure for FY2025 was -$3.5 million, down 57.67%.
  • Invested Capital for Q4 2025 was -$3.5 million at Bioregenx, down from -$2.6 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $16.0 million in Q1 2024 to a low of -$3.5 million in Q4 2025.
  • The 5-year median for Invested Capital is -$2.2 million (2023), against an average of $1.2 million.
  • The sharpest move saw Invested Capital plummeted 2110.9% in 2022, then soared 824.46% in 2024.
  • Year by year, Invested Capital stood at $115766.0 in 2021, then plummeted by 2110.9% to -$2.3 million in 2022, then skyrocketed by 33.6% to -$1.5 million in 2023, then tumbled by 45.0% to -$2.2 million in 2024, then plummeted by 57.67% to -$3.5 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at -$3.5 million, -$2.6 million, and -$2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.